On Sep 15, Biomerica Inc Submitted To FDA The Final H. Pylori Data-Set Requested By FDA During FDA's Recent Review Of The 510-k Filed By Co
Portfolio Pulse from Benzinga Newsdesk
Biomerica Inc has submitted the final H. Pylori data-set to the FDA, as requested during the FDA's recent review of the 510-k filed by the company.
September 19, 2023 | 5:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biomerica's submission of the final H. Pylori data-set to the FDA could potentially expedite the review process of the 510-k filed by the company.
The submission of the final H. Pylori data-set was a requirement by the FDA during its recent review of the 510-k filed by Biomerica. This submission could potentially expedite the review process, which could have a positive impact on the company's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100